Tandlægerne Vadum ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  2.4% 4.8% 4.5% 4.4% 3.5%  
Credit score (0-100)  63 43 46 46 54  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  4,700 4,554 4,894 5,398 5,669  
EBITDA  717 276 331 326 490  
EBIT  429 -25.2 142 208 401  
Pre-tax profit (PTP)  409.3 -49.3 124.5 204.6 400.9  
Net earnings  323.0 -39.1 87.6 159.4 312.7  
Pre-tax profit without non-rec. items  409 -49.3 125 205 401  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  252 516 342 224 134  
Shareholders equity total  791 752 839 499 512  
Interest-bearing liabilities  313 350 1.7 3.1 2.4  
Balance sheet total (assets)  2,015 1,672 1,463 1,255 969  

Net Debt  -618 -428 -899 -879 -665  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,700 4,554 4,894 5,398 5,669  
Gross profit growth  -4.1% -3.1% 7.5% 10.3% 5.0%  
Employees  7 7 7 7 7  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,015 1,672 1,463 1,255 969  
Balance sheet change%  33.6% -17.1% -12.5% -14.2% -22.8%  
Added value  717.2 276.4 331.4 397.1 490.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -515 -216 -379 -236 -179  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 -1.0 1.0 2.0 3.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  9.1% -0.6% 2.9% 3.8% 7.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  24.4% -1.3% 9.1% 15.3% 36.1%  
ROI %  42.1% -2.1% 14.2% 30.9% 78.9%  
ROE %  51.3% -5.1% 11.0% 23.8% 61.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  39.2% 45.0% 57.8% 39.7% 52.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -86.2% -154.7% -271.2% -270.1% -135.6%  
Gearing %  39.5% 46.6% 0.2% 0.6% 0.5%  
Net interest  0 0 0 0 0  
Financing costs %  6.7% 7.4% 10.0% 127.6% 1.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.4 1.3 1.8 1.4 1.8  
Current Ratio  1.4 1.3 1.8 1.4 1.8  
Cash and cash equivalent  930.6 777.5 900.4 882.3 667.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  440.9 283.9 496.6 273.9 376.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  102 39 47 57 70  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  102 39 47 47 70  
EBIT / employee  61 -4 20 30 57  
Net earnings / employee  46 -6 13 23 45